1000198-76-4 Usage
Uses
Used in Pharmaceutical Industry:
3-[4-(Trifluoromethyl)phe...] is used as a chemical intermediate for the synthesis of new drug compounds due to its unique structure and properties. Its trifluoromethyl group and phenyl ring provide opportunities for the development of pharmaceuticals with specific therapeutic targets and improved pharmacokinetic profiles.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-[4-(Trifluoromethyl)phe...] is used as a starting material for the design and synthesis of new chemical entities. Its structural features allow for the exploration of various chemical modifications, potentially leading to the discovery of innovative therapeutic agents with enhanced efficacy and selectivity.
Used in Drug Development:
3-[4-(Trifluoromethyl)phe...] is utilized in drug development processes to create novel pharmaceuticals with potential applications in treating various diseases and conditions. Its unique properties may contribute to the development of drugs with improved pharmacological profiles, including better absorption, distribution, metabolism, and excretion characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 1000198-76-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,1,9 and 8 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1000198-76:
(9*1)+(8*0)+(7*0)+(6*0)+(5*1)+(4*9)+(3*8)+(2*7)+(1*6)=94
94 % 10 = 4
So 1000198-76-4 is a valid CAS Registry Number.
1000198-76-4Relevant academic research and scientific papers
RORγ ANTAGONIST AND APPLICATION THEREOF IN MEDICINE
-
, (2020/02/06)
Provided herein are compounds as RORγ antagonist having Formula (I). The compounds or pharmaceutical composition thereof can be used for regulating Retinoid-related orphan receptor gamma t (RORγt). Also provided herein are methods of preparation of the compounds and composition thereof, and uses thereof in treating or preventing RORγt mediated inflammation or autoimmune diseases in mammals, particularly humans.
Substituted phenyl methanone derivatives
-
Page/Page column 8, (2008/06/13)
The present invention relates to compounds of formula I wherein R1, R2, R3, X, n, and m are as defined herein and to pharmaceutically acceptable acid addition salts thereof, to pharmaceutical compositions containing them,
